Business Description
Zhejiang AngliKang Pharmaceutical Co Ltd
ISIN : CNE100003GC2
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.48 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | 2.66 | |||||
Interest Coverage | 15.27 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.01 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.1 | |||||
3-Year EBITDA Growth Rate | 4.1 | |||||
3-Year EPS without NRI Growth Rate | -9 | |||||
3-Year FCF Growth Rate | 10.2 | |||||
3-Year Book Growth Rate | 6.3 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.45 | |||||
9-Day RSI | 58.47 | |||||
14-Day RSI | 53.37 | |||||
6-1 Month Momentum % | -11.56 | |||||
12-1 Month Momentum % | -17.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.13 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 1.19 | |||||
Days Inventory | 167.49 | |||||
Days Sales Outstanding | 44.02 | |||||
Days Payable | 165.79 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.88 | |||||
Dividend Payout Ratio | 0.41 | |||||
3-Year Dividend Growth Rate | -14.3 | |||||
Forward Dividend Yield % | 1.88 | |||||
5-Year Yield-on-Cost % | 1.89 | |||||
Shareholder Yield % | -6.87 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.61 | |||||
Operating Margin % | 13.31 | |||||
Net Margin % | 8.51 | |||||
FCF Margin % | 9.35 | |||||
ROE % | 8.88 | |||||
ROA % | 4.72 | |||||
ROIC % | 12.38 | |||||
ROC (Joel Greenblatt) % | 37.59 | |||||
ROCE % | 10.36 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 23.03 | |||||
PE Ratio without NRI | 21.53 | |||||
Shiller PE Ratio | 24.18 | |||||
Price-to-Owner-Earnings | 53.32 | |||||
PEG Ratio | 6.73 | |||||
PS Ratio | 1.95 | |||||
PB Ratio | 2.02 | |||||
Price-to-Tangible-Book | 2.91 | |||||
Price-to-Free-Cash-Flow | 21.53 | |||||
Price-to-Operating-Cash-Flow | 11.77 | |||||
EV-to-EBIT | 13.22 | |||||
EV-to-EBITDA | 13.22 | |||||
EV-to-Revenue | 1.8 | |||||
EV-to-FCF | 19.26 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-Graham-Number | 1.67 | |||||
Price-to-Net-Current-Asset-Value | 24.95 | |||||
Earnings Yield (Greenblatt) % | 7.56 | |||||
FCF Yield % | 4.74 | |||||
Forward Rate of Return (Yacktman) % | 6.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zhejiang AngliKang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,625.867 | ||
EPS (TTM) (Â¥) | 0.69 | ||
Beta | 0.52 | ||
Volatility % | 32.97 | ||
14-Day RSI | 53.37 | ||
14-Day ATR (Â¥) | 0.649663 | ||
20-Day SMA (Â¥) | 15.5795 | ||
12-1 Month Momentum % | -17.4 | ||
52-Week Range (Â¥) | 11.84 - 22.59 | ||
Shares Outstanding (Mil) | 201.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zhejiang AngliKang Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zhejiang AngliKang Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Zhejiang AngliKang Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940)'s stock price today?
When is next earnings date of Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940)?
Does Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |